Skip to Content
  1. All products
  2. Longevity & Anti-Aging
  3. MOTS-C
  4. Longevity & Anti-Aging
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
MOTS-C

MOTS-C

Lyophilized Vial · Subcutaneous Store refrigerated at 2-8 C and protect from heat and light. 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 54.00 $ 54.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Cellular energy regulation, metabolic optimization, exercise performance, glucose metabolism, insulin sensitivity, endurance, fat loss, metabolic syndrome support, anti-aging

MOTS-C es un péptido derivado de mitocondrias que desempeña un papel clave en la regulación de la energía celular, la optimización metabólica y el rendimiento del ejercicio. Mejora el metabolismo de la glucosa, mejora la sensibilidad a la insulina y aumenta la resistencia. MOTS-C se usa a menudo para perder grasa, apoyar el síndrome metabólico y combatir el envejecimiento. Es particularmente eficaz cuando se combina con protocolos de entrenamiento activo u otros potenciadores metabólicos.

Clinical Indications
Weight management protocolsInsulin sensitivity supportMetabolic risk reduction plans
Recommended Stacking Protocols
✓
5-Amino-1MQ
Enhances mitochondrial fat-burning synergy
✓
NAD+
For deep cellular energy and anti-aging
✓
Tesamorelin
Pairs well for body composition goals

Mechanism of Action - Weight Management / Metabolic Pathway

Targeted Signaling
Supports protocol objectives for MOTS-C.
Clinical Modulation
Allows dose and schedule adjustments by response.
Outcome Tracking
Pairs with clinician monitoring for iterative optimization.
Starting Dose
5-15mg per dose 2-3 times per week
Initiation phase for tolerance and baseline response.
Titration
Escalate by protocol
Maintenance Range
Maintain physician-directed target
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis tipica: 5-15 mg por dosis

Frecuencia: 2-3 veces por semana o segun indicacion

Momento: Mejor inyectar por la mañana o antes del entrenamiento

Period Dose Phase Clinical Notes
Typical Dose 5-15mg per dose 2-3 times per week maintenance Best injected in the morning or pre-workout
Weeks 3-6 Escalation phase escalation Increase per protocol if tolerated.
Week 7+ Maintenance phase maintenance Maintain target dose and reassess monthly.
Preparation Protocol
  1. MOTS-C se suministra como polvo liofilizado.
  2. MOTS-C debe reconstituirse con agua bacteriostática antes de su uso.
  3. El volumen de reconstitución varía ligeramente según el tamaño del vial para mantener una dosificación sencilla.
1
Inspect vial
Confirm vial integrity, lot, and expiration before use.
2
Aseptic reconstitution
Disinfect stopper and add bacteriostatic water slowly.
3
Gentle dissolution
Swirl gently until the solution is clear and homogeneous.
4
Prepare dose
Draw dose according to reconstitution conversion guidance.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 10 mg
BW: 2 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
5mg 100 units (1mL) - 2 doses
10mg 200 units (2mL) - 1 dose
Identity
  • Product Name: MOTS-C
  • Product Type: Vial | Subcutaneous Injection
  • Strength Options: 10 mg, 40 mg
  • Available Strengths: 10mg, 40mg
Quality & Purity
  • Purity: >= 99%
  • Sterility: Aseptic handling required
  • Purity: 99%+
Storage & Handling
  • Storage: 2-8 C refrigerated
  • Handling: Avoid heat, shaking, and direct light
  • Storage: Refrigerate after reconstitution (2-8°C)

Timing: Timing:Best injected in the morning or pre-workout

Storage: Store refrigerated at 2-8 C and protect from heat and light.

Frequency: Frequency:2-3 timesperweekor asdirected

Cycle: Cycle length and cadence are clinician-defined per patient profile.

Injection Sites: Rotate approved injection sites to reduce local irritation risk.